274: Covid’s latest surge, Alnylam at the FDA, & the end of an era
The Readout Loud
00:00
FDA Advisory Panel Votes in Favor of Alnylam Drug for ATTR CM
The FDA advisory panel votes in favor of an Alnylam drug for ATTR CM, despite debates about the meaningfulness of the results. Alnylam is likely to win FDA approval for the drug.
Transcript
Play full episode
